Can a patient on norepinephrine be safely mobilized, and under what conditions?

• A. Yes, if dose is stable and MAP maintained; avoid increasing vasopressors solely for mobilization; monitor closely and follow protocol
• B. Not safe under any circumstances
• C. Only if vasopressor dose is increasing
• D. Only after stopping vasopressors

Answer: (A)

Mobilizing a patient on norepinephrine is possible when the patient remains hemodynamically stable. The key idea is that the vasopressor dose is not changing and mean arterial pressure stays within a safe range during the activity. If the norepinephrine dose is stable and MAP is maintained, gradual mobilization can be attempted according to a protocol, with close monitoring. This approach recognizes that moving or sitting up can affect venous return and tissue perfusion, so stability is the signal that the patient can tolerate activity without risking hypotension or organ hypoperfusion.

Importantly, you should not escalate vasopressors solely to enable mobilization, because that would indicate instability and could create more risk. Continuous monitoring during the mobilization—blood pressure, heart rate and rhythm, oxygen saturation, signs of ischemia or poor perfusion, and the patient’s symptoms—helps ensure safety and allows you to stop or back off if intolerance occurs. Protocol-driven criteria guide when and how to progress, rather than proceeding solely on a desire to mobilize.

In short, the safest, most reasonable approach is to mobilize when norepinephrine dose is stable and MAP is maintained, with careful monitoring and adherence to a predefined protocol.